Cosmos Health expands e-commerce to Australia and New Zealand

Chicago, Illinois - Cosmos Health Inc., a healthcare company listed on the NASDAQ as COSM, has announced the launch of its online retail and subscription services in Australia, New Zealand, and the wider Oceania region. The company's press release stated that customers in these countries can now buy its products directly through online stores, with an option to subscribe for regular deliveries.

The expansion follows the successful implementation of Cosmos Health's direct-to-consumer business model in the United States, which currently boasts 8,940 active subscriptions and 14,624 online checkout orders as of Sunday. The company expressed its intention to continue exploring other international markets for its direct-to-consumer subscription model.

The CEO of Cosmos Health, Greg Siokas, noted that the subscription model has rapidly gained traction in the United States, attracting thousands of customers who prefer to receive the company's products on a recurring basis. Cosmos Health boasts a diverse portfolio of pharmaceutical and nutraceutical brands, and its products are manufactured in its subsidiary, Cana Laboratories S.A., which adheres to European Good Manufacturing Practices and is certified by the European Medicines Agency.

The company distributes its pharmaceuticals and parapharmaceuticals through subsidiaries in Greece and the United Kingdom. Headquarters and distribution centers are located in Thessaloniki and Athens, Greece, and in Harlow, UK.